52 participants
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-10-01
- Start Date:
- 2012-03-31
- Completion:
- 2013-08-31
Conditions
- Hepatitis C
- HIV
Interventions
- DRUG